Lenvima
Generic: Lenvatinib
- Manufacturer
- Eisai
- NDC
- 62856-704
- RxCUI
- 1604345
- Route
- ORAL
- ICD-10 indication
- C73
Affordability Check
How much will you actually pay for Lenvima?
In 30 seconds, see every legitimate way to afford Lenvima — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Lenvima
What is this medication?
Lenvima, which contains the active ingredient lenvatinib, is a prescription medicine categorized as a kinase inhibitor. This medication functions by targeting and blocking specific proteins that help cancer cells grow and divide. It also works by interfering with the development of new blood vessels that tumors need to grow and spread. By inhibiting these pathways, Lenvima helps to slow down or stop the progression of the disease in patients with certain advanced malignancies.
Doctors prescribe Lenvima to treat several specific types of cancer. It is commonly used for differentiated thyroid cancer when radioactive iodine treatment is no longer effective. It is also approved for the first-line treatment of patients with hepatocellular carcinoma, a common form of liver cancer, when the tumor cannot be surgically removed. Furthermore, Lenvima is used in combination with other drugs to treat advanced renal cell carcinoma, which affects the kidneys, and advanced endometrial carcinoma, which is a type of uterine cancer that has progressed despite prior therapy.
Copay & patient assistance
- Patient Copay Amount: As little as $0 per prescription
- Maximum Annual Benefit Limit: $10,000 per year
- Core Eligibility Restrictions: Must have private, commercial insurance; not valid for patients enrolled in state or federal healthcare programs (including Medicare, Medicaid, Medigap, VA, DoD, or TRICARE); must be a U.S. resident; not valid for cash-paying customers; must be 18 years or older to use the card for yourself
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Lenvatinib.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Lenvima →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Lenvatinib →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How Lenvima appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
30%
1,629 of 5,499 plans
Most common tier
Tier 5
On 75% of covering formularies
Prior authorization required
100%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 31 | 22% |
| Tier 4 (non-preferred brand) | 3 | 2% |
| Tier 5 (specialty) | 107 | 75% |
| Tier 6 | 1 | 1% |
Step therapy: 0% of formularies
Quantity limits: 65% of formularies
Coverage breadth: 142 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
EVEROLIMUS
Treats same condition · Everolimus
AVMAPKI FAKZYNJA CO-PACK
Treats same condition · avutometinib potassium and defactinib hydrochloride
Fludeoxyglucose F18
Treats same condition · Fludeoxyglucose F18
Portrazza
Treats same condition · necitumumab
Pilocarpine Hydrochloride
Treats same condition · Pilocarpine Hydrochloride
TEPADINA
Treats same condition · THIOTEPA
AVGEMSI
Treats same condition · Gemcitabine
CLENPIQ
Treats same condition · SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
Niva Thyroid
Treats same condition · thyroid, porcine
Kisunla
Treats same condition · donanemab-azbt
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.